Constellation Brands
STZ
$0.00
+1.60%
Constellation Brands is the largest alcoholic beverage company in the U.S., with a dominant position in the high-margin imported beer market through its exclusive rights to sell Modelo and Corona brands. The company is a clear market leader in the U.S. beer import segment, deriving over 90% of its revenue from this resilient and fast-growing category, while it has strategically pruned its lower-margin wine and spirits portfolio. The current investor narrative is focused on the company's ability to sustain its premium beer growth against a backdrop of consumer pressure, with recent attention on its Q4 earnings beat being overshadowed by disappointing forward profit guidance, which has tempered near-term growth expectations.…
STZ
Constellation Brands
$0.00
Related headlines
Investment Opinion: Should I buy STZ Today?
Rating: HOLD. The core thesis is that STZ presents a compelling but premature value opportunity; its deep valuation discount is warranted by near-term fundamental deterioration, requiring investors to wait for concrete signs of a growth turnaround before committing capital.
Supporting evidence includes a forward P/E of 11.93x (46% below sector average), a strong dividend yield of 2.6% backed by $1.76B in annual FCF, and a high-quality business evidenced by a 20.9% ROE and 31.3% operating margin. However, these strengths are counterbalanced by a 9.8% YoY revenue decline, a high debt-to-equity ratio of 1.39, and a stock price languishing near the bottom of its 52-week range, reflecting justified market caution.
The two biggest risks that could invalidate a future Buy thesis are: 1) Revenue growth failing to re-accelerate back to positive territory, and 2) Further earnings volatility or guidance cuts exacerbating leverage concerns. This Hold rating would upgrade to a Buy if the forward P/E compresses further toward 10x alongside a return to positive quarterly revenue growth, or if the stock sustainably breaks above key technical resistance near $165. It would downgrade to a Sell if revenue decline accelerates beyond 10% or if the dividend payout ratio rises above 60%, signaling cash flow stress. The stock is currently fairly valued relative to its challenged near-term prospects but deeply undervalued relative to its long-term earnings power.
Sign up to view all
STZ 12-Month Price Forecast
The outlook for STZ is a battle between its durable, cash-generative business model and its deteriorating near-term growth profile. The base case of range-bound trading is most likely, as the market needs time to assess whether the Q4 revenue decline is an anomaly or a trend. The substantial valuation discount offers protection, but it is a discount for a reason. The stance would upgrade to bullish on confirmation of revenue stabilization and a successful hold of the $126.45 support level. It would turn bearish if the next earnings report shows accelerating declines or a contraction in the robust 31.3% operating margin.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Constellation Brands's 12-month outlook, with a consensus price target around $0.00 and implied upside of — versus the current price.
Average Target
$0.00
7 analysts
Implied Upside
—
vs. current price
Analyst Count
7
covering this stock
Price Range
$0 - $0
Analyst target range
Insufficient analyst coverage data is available to provide a detailed consensus view, as the provided data only includes estimates for EPS and revenue, not explicit price targets or ratings distributions. The limited data shows seven analysts providing estimates, with an average EPS forecast of $15.72 for the upcoming period. The absence of a clear target price range and rating breakdown suggests this large-cap stock may have limited sell-side coverage in the provided dataset, which is unusual and could indicate a data gap. Typically, a stock of this size would have broader coverage; the lack of it here limits the ability to gauge Wall Street sentiment. The recent institutional ratings show a mix of actions, including a Citigroup upgrade from Neutral to Buy in March 2026 and reiterated Buy/Outperform ratings from Needham, UBS, and Wells Fargo in January 2026, indicating a generally positive but cautious analyst stance focused on execution of its beer-led strategy.
Bulls vs Bears: STZ Investment Factors
The investment debate for STZ centers on a compelling valuation disconnect versus deteriorating near-term fundamentals. The bull case, supported by a deep sector discount, strong cash generation, and a defensive low-beta profile, currently holds stronger evidence for long-term value investors. However, the bear case presents immediate and tangible risks, primarily the 9.8% revenue decline and earnings volatility, which have justifiably spooked the market. The single most important tension is whether the recent revenue contraction is a temporary blip for its dominant beer brands or the beginning of a sustained slowdown. The resolution of this growth trajectory, against the backdrop of high leverage, will determine if the current valuation discount is a trap or a tremendous opportunity.
Bullish
- Deep Valuation Discount to Sector: STZ trades at a forward P/E of 11.93x, a 46% discount to the implied industry average of 22x. This significant discount is not justified by its profitability, as the company maintains robust gross margins above 51% and a strong ROE of 20.9%.
- Strong Free Cash Flow & Dividend: The company generates substantial cash, with TTM free cash flow of $1.76 billion supporting a sustainable 2.6% dividend yield and a conservative payout ratio of 42.4%. This provides a defensive income floor for investors.
- Dominant Market Position in Resilient Segment: Over 90% of revenue comes from the high-margin, imported Mexican beer segment where STZ holds exclusive U.S. rights to Modelo and Corona. This provides a durable competitive moat and pricing power, evidenced by a 31.3% operating margin.
- Low Beta Provides Defensive Stability: With a beta of 0.384, STZ exhibits significantly lower volatility than the broader market (SPY). This makes it a relative safe haven during market downturns, as demonstrated by its outperformance during recent SPY weakness.
Bearish
- Revenue Contraction and Growth Deceleration: Most recent quarterly revenue of $2.22 billion represents a 9.8% year-over-year decline, a stark reversal from prior growth. This raises concerns about the sustainability of the core beer business's momentum in a pressured consumer environment.
- Earnings Volatility and Q4 Loss: The company posted a significant net loss of -$375.3 million in Q4 2025, highlighting earnings volatility driven by impairments or one-time items. This inconsistency complicates valuation and undermines investor confidence in near-term guidance.
- High Financial Leverage: A debt-to-equity ratio of 1.39 indicates significant leverage on the balance sheet. While covered by strong cash flow, this increases financial risk if interest rates remain elevated or if beer cash flows were to weaken unexpectedly.
- Technical Downtrend and Underperformance: The stock is down 12.5% over the past year and trades near the bottom 21% of its 52-week range ($148.51 vs. high of $178.14). This persistent selling pressure and stark underperformance vs. the SPY's +22.9% gain reflects deep market skepticism.
STZ Technical Analysis
The stock is in a pronounced downtrend, having declined 12.54% over the past year, and is currently trading at approximately 21% of its 52-week range (price of $148.51 relative to a 52-week high of $178.14 and low of $126.45). This positioning near the lower end of the range suggests the stock is in a value zone, but also reflects significant technical damage and persistent selling pressure. Recent momentum shows a slight rebound, with the stock up 5.69% over the past month, which contrasts sharply with its 1-year decline and a 1.09% drop over the past three months. This divergence suggests a potential near-term relief rally or consolidation after a severe sell-off, but the longer-term trend remains bearish. Key technical support is anchored at the 52-week low of $126.45, while resistance sits at the 52-week high of $178.14. A break below support would signal a continuation of the downtrend, whereas a sustained move above the $150-$155 area is needed to suggest a reversal. With a beta of 0.384, the stock exhibits significantly lower volatility than the broader market (SPY), indicating it has been a relative safe haven during recent market turbulence, though its recent underperformance against the SPY's 22.86% 1-year gain is stark.
Beta
0.38
0.38x market volatility
Max Drawdown
-34.8%
Largest decline past year
52-Week Range
$126-$178
Price range past year
Annual Return
-11.8%
Cumulative gain past year
| Period | STZ Return | S&P 500 |
|---|---|---|
| 1m | -3.6% | +0.7% |
| 3m | -5.6% | +15.1% |
| 6m | +4.6% | +9.7% |
| 1y | -11.8% | +25.0% |
| ytd | +0.0% | +9.5% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
STZ Fundamental Analysis
Revenue growth has decelerated, with the most recent quarterly revenue of $2.22 billion representing a 9.8% year-over-year decline. This contraction is a significant shift from prior periods of growth, driven primarily by the Beer segment's $2.01 billion in sales, which still constitutes the vast majority of the business. The company remains profitable, posting net income of $502.8 million in its latest quarter with a robust gross margin of 53.2% and an operating margin of 31.3%. However, profitability has been inconsistent, with a notable net loss of $375.3 million in the Q4 2025 period, highlighting potential volatility in earnings due to one-time items or impairments. The balance sheet carries a moderately high debt-to-equity ratio of 1.39, indicating significant leverage, but this is offset by strong cash generation, with trailing twelve-month free cash flow of $1.76 billion providing ample coverage for its dividend (payout ratio of 42.4%) and share repurchases. The current ratio of 1.08 shows adequate short-term liquidity, and a return on equity of 20.9% demonstrates efficient use of shareholder capital, though the financial health is heavily dependent on the sustained cash flow from its core beer business.
Quarterly Revenue
$2.2B
2025-11
Revenue YoY Growth
-0.09%
YoY Comparison
Gross Margin
+0.53%
Latest Quarter
Free Cash Flow
$1.8B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is STZ Overvalued?
Given the company's consistent profitability, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE is 16.42x, while the forward PE is 11.93x, implying the market expects a significant 27% growth in earnings over the next year. Compared to the provided industry average PE of 22x (implied from the data's context), STZ trades at a substantial 25% discount to its sector. This discount may reflect concerns over recent revenue declines and the disappointing forward guidance mentioned in recent news. Historically, the stock's own PE ratio has fluctuated significantly, ranging from negative figures during loss-making quarters to highs above 80x. The current trailing PE of 16.42x sits below its mid-cycle historical average, suggesting the stock is not at an extreme valuation relative to its own history, but is pricing in a more muted growth profile. The forward PE compression to 11.93x indicates the market has already priced in a period of earnings adjustment or recovery.
PE
16.4x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -21x~6710x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
12.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are elevated due to high leverage and earnings inconsistency. The debt-to-equity ratio of 1.39 is substantial for a consumer staples company, increasing refinancing risk in a higher-rate environment. More concerning is the volatile earnings profile, exemplified by a net loss of -$375.3M in Q4 2025 following a strong profit of $502.8M in Q3, which creates uncertainty around forward guidance. Furthermore, over 90% revenue concentration in the U.S. beer import segment, while a strength, is also a risk if consumer preferences shift or pricing power erodes, as suggested by the recent 9.8% YoY revenue decline.
Market & Competitive Risks include valuation compression and sector-specific headwinds. Trading at a 46% discount to the sector's forward P/E suggests the market has already priced in significant pessimism, limiting further multiple contraction risk. However, the stock's 12.5% annual decline and 35% underperformance versus the SPY indicate it is already in a severe sector rotation out of consumer staples. Competitive and regulatory risks are moderated by its exclusive import rights, but the broader industry is facing a 'growth hangover,' as noted in recent news about defensive consolidation, which could pressure long-term growth expectations for all players.
Worst-Case Scenario involves a perfect storm of sustained revenue declines, margin compression, and a credit rating downgrade. If the Q4 guidance miss signals the start of a prolonged downturn for Modelo/Corona, revenue could fall further, straining the high debt load and forcing dividend cuts. In this adverse scenario, the stock could re-test its 52-week low of $126.45, representing a potential downside of approximately -15% from the current price of $148.51. A breach of this support could trigger a steeper decline towards the $115-$120 range, aligning with a max historical drawdown of -34.75%, though the low beta of 0.384 should provide some downside cushion relative to the market.
FAQ
The key risks, in order of severity, are: 1) Operational: Sustained revenue decline, as evidenced by the most recent 9.8% YoY drop, which could indicate waning brand strength. 2) Financial: High leverage with a debt-to-equity ratio of 1.39, increasing interest expense risk. 3) Earnings Quality: Volatility in profitability, highlighted by the Q4 2025 net loss of -$375.3M following a profitable quarter, creating guidance uncertainty. 4) Market/Sentiment: Persistent technical downtrend and severe underperformance (-35% vs. SPY over 1 year), which can become a self-fulfilling prophecy as momentum investors exit.
The 12-month forecast presents three scenarios. The Base Case (60% probability) sees the stock trading between $150 and $165, as growth stabilizes but the valuation discount persists. The Bull Case (25% probability) targets $178 to $185 on a return to growth and sector re-rating. The Bear Case (15% probability) warns of a drop to the $126 to $135 range if revenue declines worsen. The base case is most likely, anchored by the analyst EPS consensus of $15.72 and the assumption that the company's strong cash flows will prevent a collapse, but growth will remain elusive in the near term.
STZ is deeply undervalued relative to its sector but fairly valued relative to its own challenged near-term prospects. Its forward P/E of 11.93x is a 46% discount to the implied industry average of 22x, which is significant for a company with a 20.9% ROE. Historically, its own trailing P/E of 16.42x is below its mid-cycle average, suggesting it is not expensive. The market is paying a discounted price because it expects earnings growth of 27% (implied by the forward P/E compression) but is skeptical it will be achieved due to recent revenue declines. The valuation implies the market expects a period of stagnation or very modest recovery.
STZ is a good buy for a specific type of investor: a patient, value-oriented investor seeking income and defensive stability. The 46% discount to the sector's forward P/E (11.93x vs. ~22x) and the 2.6% sustainable dividend yield present a compelling risk/reward for the long term. However, it is not a good buy for growth investors or those with a short horizon, given the near-term headwinds of a 9.8% revenue decline and high financial leverage (D/E of 1.39). The current Hold rating suggests waiting for a clearer inflection in fundamentals before committing new capital.
STZ is unequivocally suitable for long-term investment, with a recommended minimum holding period of 3-5 years. Its low beta of 0.384 and dividend income profile make it a poor candidate for short-term trading, which requires higher volatility and momentum. The investment thesis is based on the company's durable competitive moat in beer imports, which will take time to overcome current consumer pressures and justify a higher valuation. Long-term investors can collect the dividend while waiting for the growth cycle to turn. Short-term traders would be better served by more volatile, catalyst-driven stocks.